Search

At AseBio, we reaffirm our commitment to continuing to work with European and national institutions to ensure that the implementation of the Regulation fully harnesses the potential of NGTs in support

The strategic framework agreement deepens the long-standing partnership, leveraging Artificial Intelligence and High-Performance Computing to identify new opportunities of collaboration in the

The event, organized by AseBio and the Salamanca City Council, was held this Tuesday at the Congress and Exhibition Center of the Tormes capital. It brought together 120 attendees from 75

We interviewed Germán Alejandro Sánchez Martín, Founder & CEO of Opportunity Health, the company that won the BIOSPAIN 2025 Pitch Presentation.

The announcement was made during the Spain–United States Business Meeting held in Boston, organized by ICEX España Exportación e Inversiones, with the participation of 40 Spanish companies and nearly

Meet Atlas Molecular Pharma, our new member. We spoke with Susana Castel, CEO.

The event brought together experts from hospitals, research organizations, industry and innovation ecosystems to co-create sustainable service models for the Paediatric Health Data Space (PHDS).

At AseBio, we believe this Executive Order creates uncertainty for the European biotechnology sector—especially for companies exporting to the U.S.—and we will continue working to help our member

The company received the recognition from the Ministry of Industry, presented by King Felipe VI, for its commitment to biotechnological innovation, industrial capacity and strengthening Europe’s

HIPRA Biotech Services reaches key milestones in its first year of operations, including signing its first agreement in just nine months and advancing new collaboration opportunities with European